As Sanofi's Pompe drug shortage drags on, some patients struggle to access treatments
An ongoing shortage of Sanofi’s Pompe disease treatment is forcing some patients to miss critical doses. They worry their health is at risk.
This is a brief. The reporting belongs to CNBC — read the complete story, with full context and credits, at the source.
Read the full story at CNBC ↗cnbc.com
More from the Business desk
Just in
The surprising reason the U.S. economy is speeding up — and might have more room to run
Just in

Anthropic opens at $111.50 per share after largest IPO ever
Just in